☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
nmpa
New Drug Designations - September 2024
October 29, 2024
New Drug Designations - April 2024
May 30, 2024
Sobi’s Gamifant (emapalumab) Received Recommendation for Approval in China from CDE to Treat Adult and Paediatric Patients with Pr...
February 28, 2022
Antengene's Selinexor (ATG-010) Receives NMPA's IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma
November 19, 2021
Antengene's Receives NMPA's IND Approval for P-Ib MATCH Study of ATG-008 (onatasertib) ATG-010 (selinexor) to Treat Diffuse Large...
November 2, 2021
Everest's SPR206 Receives the NMPA's IND Approval for the Treatment of MDR Gram-Negative Bacterial Infections
September 24, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.